M.D. Sass Investors Services, Inc. Gilead Sciences, Inc. Transaction History

M.D. Sass Investors Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $20 Million - $23.3 Million	-308,280 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $689,794 - $840,936	-9,470 Reduced 2.98%	308,280 $23.2 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $2.05 Million - $2.4 Million	-28,765 Reduced 8.3%	317,750 $22.8 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $25 Million - $29.6 Million	346,515	346,515 $28.1 Million

1,883

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86.2B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of M.D. Sass Investors Services, Inc., based on Form 13F filings with the SEC.

Stay updated on M.D. Sass Investors Services, Inc. with notifications on news.